124 related articles for article (PubMed ID: 38340912)
1. Engineering novel scaffolds for specific HDAC11 inhibitors against metabolic diseases exploiting deep learning, virtual screening, and molecular dynamics simulations.
Li J; Chen X; Liu R; Liu X; Shu M
Int J Biol Macromol; 2024 Mar; 262(Pt 2):129810. PubMed ID: 38340912
[TBL] [Abstract][Full Text] [Related]
2. Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor.
Baselious F; Hilscher S; Robaa D; Barinka C; Schutkowski M; Sippl W
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279359
[TBL] [Abstract][Full Text] [Related]
3. Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study.
Baselious F; Robaa D; Sippl W
Comput Biol Med; 2023 Dec; 167():107700. PubMed ID: 37972533
[TBL] [Abstract][Full Text] [Related]
4. HDAC11, an emerging therapeutic target for metabolic disorders.
Chen H; Xie C; Chen Q; Zhuang S
Front Endocrinol (Lausanne); 2022; 13():989305. PubMed ID: 36339432
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning and Structure-Based Virtual Screening for Drug Discovery against NEK7: A Novel Target for the Treatment of Cancer.
Aziz M; Ejaz SA; Zargar S; Akhtar N; Aborode AT; A Wani T; Batiha GE; Siddique F; Alqarni M; Akintola AA
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807344
[TBL] [Abstract][Full Text] [Related]
6. The role of HDAC11 in obesity-related metabolic disorders: A critical review.
Yang H; Chen L; Sun Q; Yao F; Muhammad S; Sun C
J Cell Physiol; 2021 Aug; 236(8):5582-5591. PubMed ID: 33481312
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.
Uba AI; Yelekçi K
J Biomol Struct Dyn; 2018 Sep; 36(12):3231-3245. PubMed ID: 28938863
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore-enabled virtual screening, molecular docking and molecular dynamics studies for identification of potent and selective histone deacetylase 8 inhibitors.
Kashyap K; Kakkar R
Comput Biol Med; 2020 Aug; 123():103850. PubMed ID: 32658783
[TBL] [Abstract][Full Text] [Related]
9. Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice.
Bai P; Liu Y; Yang L; Ding W; Mondal P; Sang N; Liu G; Lu X; Ho TT; Zhou Y; Wu R; Birar VC; Wilks MQ; Tanzi RE; Lin H; Zhang C; Li W; Shen S; Wang C
J Med Chem; 2023 Dec; 66(23):16075-16090. PubMed ID: 37972387
[TBL] [Abstract][Full Text] [Related]
10. Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety.
Bui HTB; Nguyen PH; Pham QM; Tran HP; Tran Q; Jung H; Hong QV; Nguyen QC; Nguyen QP; Le HT; Yang SG
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408604
[TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening and molecular dynamics simulations for detecting novel candidates for allosteric inhibition of EGFRT790M.
Çoban G
J Biomol Struct Dyn; 2024; 42(2):571-597. PubMed ID: 37029759
[TBL] [Abstract][Full Text] [Related]
12. Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors.
Andrianov AM; Nikolaev GI; Shuldov NA; Bosko IP; Anischenko AI; Tuzikov AV
J Biomol Struct Dyn; 2022 Oct; 40(16):7555-7573. PubMed ID: 33855929
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation.
Kumbhar N; Nimal S; Barale S; Kamble S; Bavi R; Sonawane K; Gacche R
Sci Rep; 2022 Feb; 12(1):1712. PubMed ID: 35110603
[TBL] [Abstract][Full Text] [Related]
14. Stabilizing HDAC11 with SAHA to assay slow-binding benzamide inhibitors.
Tian Y; Lv W; Li X; Wang C; Wang D; Wang PG; Jin J; Shen J
Bioorg Med Chem Lett; 2017 Jul; 27(13):2943-2945. PubMed ID: 28501514
[TBL] [Abstract][Full Text] [Related]
15. Activity-Guided Design of HDAC11-Specific Inhibitors.
Son SI; Cao J; Zhu CL; Miller SP; Lin H
ACS Chem Biol; 2019 Jul; 14(7):1393-1397. PubMed ID: 31264832
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel inhibitors of histone deacetylase 6: Structure-based virtual screening, molecular dynamics simulation, enzyme inhibition and cell viability assays.
Uba AI; Hryb M; Singh M; Bui-Linh C; Tran A; Atienza J; Misbah S; Mou X; Wu C
Life Sci; 2024 Feb; 338():122395. PubMed ID: 38181853
[TBL] [Abstract][Full Text] [Related]
18. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations.
Arshia AH; Shadravan S; Solhjoo A; Sakhteman A; Sami A
Comput Biol Med; 2021 Dec; 139():104967. PubMed ID: 34739968
[TBL] [Abstract][Full Text] [Related]
19. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
Uba AI; Yelekçi K
Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
[TBL] [Abstract][Full Text] [Related]
20. A deep learning and docking simulation-based virtual screening strategy enables the rapid identification of HIF-1α pathway activators from a marine natural product database.
A R N; G K R
J Biomol Struct Dyn; 2024; 42(2):629-651. PubMed ID: 37038705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]